SUMMARY Two girls with asthma died suddenly in autumn-winter 1985. On clinical criteria, both had been classified as moderately severe asthmatics, had shown a stabilised disease course, and had complied with antiasthmatic medication. By chance, lung function, bronchial reactivity, and subjective perception of lung function impairment had been assessed five and a half months and one month before death, respectively. For comparative purposes, we measured lung function and bronchial reactivity in a reference group of 37 children who had asthma of the same clinical severity and who were taking the same medication. In comparison with this reference group the index subjects showed a high degree of bronchial reactivity, incomplete recovery of function after bronchodilation, and appreciably reduced perception of severe lung function impairment. Regular assessment of lung function, bronchial reactivity, and perception of breathlessness might help to identify the patient who is prone to a fatal attack of asthma.
Childhood asthma is a major health problem, but updated conce?ts improve the therapeutic approach to the disease. 2Nevertheless, there are still some children and adolescents who die of asthma, and many of these deaths occur suddenly.Y8 While there are organised attempts to identify these patients,9 such endeavours are hampered by the current lack of the objective data that are needed for identification of the subgroup at risk. There are only a few published lung function measurements from paediatric patients with asthma who later died suddenly3 5; so far, no observations on the bronchial reactivity of these patients have been reported.
We have previously studied the practical value of cold air challenge for measuring bronchial reactivity in children,10 1 and now try to assess bronchial reactivity by this method once a year in all our patients with asthma of at least moderate severity. In autumn-winter 1985, two of our patients died suddenly at home, five and a half months and one month after this functional assessment, respectively. The present study reports measurements of lung function and bronchial reactivity in these two index patients and in a reference group with asthma of comparable severity.
Patients and methods CASE 1 This girl died suddenly at the age of 14-8 years. She had been attending the local asthma clinic for the last two and a half years. Her case history showed extrinsic asthma beginning in the second year of life, three emergency hospital admissions, one hyposensitisation course with pollen antigen, and various courses of medication. In the year preceding death her asthma had appeared well stabilised by combined medication with an inhaled 12 sympathomimetic, a topical steroid, and a sustained release theophylline preparation. She attended school regularly and was able to participate in various physical activities. On clinical criteria her asthma was graded to be of moderate severity (grade three on a scale from one to four); her compliance with medication was considered to be good. A one week peak flow protocol, recorded nine months before death, showed moderately wide diurnal variations and night dipping; subsequently her evening dose of the sustained release theophylline was increased, and two puffs of the bronchodilator aerosol were recommended, when waking up at night because of asthma symptoms.
Assessment of lung function and bronchial reactivity was performed five and a half months before death. In addition, the concentration of serum theophylline, and the presence of specific IgE antibodies to 12 common allergens were determined by fluorescence polarisation immunoassay and a radioallergosorbent assay (RAST)f respectively (Abbott and Pharmacia Diagnostics). The found by RAST. After this investigation she was instructed how to use a peak flow meter at home and was asked to record her peak expiratory flow rate twice a day and when having symptoms. This was, however, only done for the next five days and was subsequently neglected.
Death occurred at home around 7.00 hours on a November morning. The girl had suffered from a common cold for five days and had told her mother at 6.30 hours that she did not want to go to school because of feeling tired and short of breath. The mother found her lifeless on the floor of her room at about 7.15 hours. After emergency transport to a local hospital, she was pronounced dead on admission. Postmortem examination showed hyperinflated lungs with extensive mucus plugging of the peripheral airways.
REFERENCE GROUP
We recruited patients from the local asthma clinic, who were older than 8 years of age, and suffering from asthma of comparable clinical severity, and who were taking the same antiasthmatic medication as the index patients (132 sympathomimetic by metered dose inhaler, topical steroid, sustained release theophylline). This resulted in a reference group of 37 patients (28 boys, nine girls) with a mean age of 11-8 years (range 8-3 to 15.2).
ASSESSMENT OF LUNG FUNCTION AND BRONCHIAL REACTIVITY
Measurements in index and reference group patients were part of a routine programme and followed the same protocol. Informed consent by patients and parents was a prerequisite for all measurements. Functional assessment was done in a stable clinical condition twice within 10 days. Patients arrived at 9.00 hours, rested for 30 minutes, and then had baseline lung function testing.
At the first visit patients then inhaled a sympathomimetic 12 bronchodilator (salbutamol, 0-02 ml of the 0*5% solution per kg of body weight) from a jet type nebuliser (Inhalierboy). Fifteen minutes after bronchodilator inhalation lung function testing was repeated.
Before the second visit, the sustained release theophylline medication was withheld for four days and the sympathomimetic for 12 hours. After baseline lung function testing, patients underwent a standardised cold air challenge according to a method described previously,1 administered by a commercially available heat exchanger (RHES, Jaeger), which was set to apply absolutely dry air with a temperature of -10°C. Each challenge consisted of four minutes of isocapnic hyperventilation at 75% of maximal voluntary ventilation. The response was assessed by lung function testing three minutes after the termination of the cold air challenge. In addition, the patients were asked before and after the cold air challenge to score their subjective feeling of chest tightness as 'none', 'mild', 'moderate', or 'severe'.
Pulmonary function tests for baseline determinations and for measuring the responses were done on a pneumotachygraph spirometer (Pneumotest Junior, Jaeger). The patients performed several forced vital capacity manoeuvres, which were recorded in form of a maximum expiratory volume time and flow volume curve. Forced expiratory volume in the first second (FEV1) and maximum expiratory flow at 25% remaining vital capacity (Vmax25) were measured and expressed as percent of predicted normal values.12 13 Thus the investigation resulted in two baselines, index patients was in the middle of the reference range for Vmax25, and in the upper part of the reference range for FEV1. For all lung function situations assessed, both index patients as well as the reference group, showed a tendency towards more obstruction in Vmax25, than in FEV1.
The perception score assessed at baseline and the functional minimum is shown in the figure. Both index patients were below or at the lower end of the reference range for both functions. Unsuspected pathology, especially tension pneumothorax, is unlikely in our two patients, but cannot be definitely exluded for case 1. Abuse of adrenergic aerosols can be excluded for causing the death of case 1, and remains a somewhat unlikely causative factor for the death of case 2. It therefore appears reasonable to assume that both index cases are true examples of 'sudden death in asthma'. Anyone who attempts to reduce the mortality from such sudden and potentially fatal attacks faces the problem of identifying the patient at risk.9 This task is related to the more general question of how to assess the severity of a disorder that is characterised by large variations in functional impairment.19
Both index patients in the present study showed a functional profile of high bronchial reactivity in addition to impaired baseline function. Any obstructive airway reaction will sooner become life threatening, if it starts from an already compromised lung function level. Lung function and airway reactivity measurements in two patients do not suffice for a general explanation of sudden death in asthma: nevertheless, our observations suggest, that repeated assessments of bronchial reactivity might be helpful for identification of the fatality prone patient.
In many cases of fatal asthma the life threatening character of the disorder had not 
